Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. - Wikidata - wikimedia - TriplyDB

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial.

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial.

http://www.wikidata.org/entity/Q46606421

about

NDUFA12L mitochondrial complex-I assembly factor: Implications for taupathies The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Coenzyme Q10 and Neurological Diseases.Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial Nutraceuticals and headache: the biological basis.Therapeutic advances in multiple system atrophy and progressive supranuclear palsy.Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone.Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.Why are there no proven therapies for genetic mitochondrial diseases?Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice.Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial.Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients.Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Drug development for rare mitochondrial disorders Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis.Coenzyme Q10 effects in neurodegenerative disease.Frontotemporal lobar degeneration: current perspectives.Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy.Design and implementation of the first randomized controlled trial of coenzyme CoQ₁₀ in children with primary mitochondrial diseases Bioenergetic medicine.Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations.Rational therapeutic approaches to progressive supranuclear palsy.Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.Mitochondrial dysfunction as a therapeutic target in progressive supranuclear palsy.Mitochondrial dysfunction and Down's syndrome: is there a role for coenzyme Q(10) ?Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy.Fifty years of progressive supranuclear palsy.Clinical trials: past, current, and future for atypical Parkinsonian syndromes.CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial.Are there treatments for atypical parkinsonism? An update on actual options.A Review of Treatment Options for Progressive Supranuclear Palsy.Diagnostic Approach to Atypical Parkinsonian Syndromes.Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale.Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease.Emerging Diagnostic and Therapeutic Strategies for Tauopathies.In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy.Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation.

P2860

Q26764822-75C771C6-540F-4761-AA9A-D60C2BDFDCCC Q28485924-8A316BFC-F754-4DD3-A591-068667BBAE81 Q30440307-2725A087-232B-41E5-85D5-B3C411334194 Q33837238-E3A2BA10-38E4-4936-A788-384F88C41094 Q34031302-B4638177-DD30-4B98-A0CF-2F844A7F37E2 Q34166931-C1CE41D5-9A7D-47C3-A18F-9F80A171407B Q34487619-50436B5A-D385-4342-A9C3-FAC175C0DE3C Q34685307-B35D2C96-7A30-4434-9EA9-ED14DF41C01C Q35045060-8703F6BB-AB05-45FE-BF7F-F7A78704A621 Q35140660-8AD3E11D-4435-4BC4-A84D-B29AC58CE90E Q35162928-63178844-5BB4-44D0-9BB5-1E85DA2A52B8 Q35756089-F78AC0D2-D246-4E4E-829D-3B01E63F96B6 Q35902883-F1EED7DE-EC7F-4E40-8C53-9328384A3C4B Q35928302-B171CCC1-0992-44E0-A1F6-028D28262F6E Q35958359-DC479CA2-811C-4D85-A445-9AA7E0D78131 Q36762826-4492423D-2CFA-45FE-88F8-8DB34DFF7ADE Q36886627-FDA32D8A-4C50-45A1-8453-7CFF5EF508FE Q37315448-6602A41B-69A7-4787-9415-329D1D8B4D92 Q37448888-79610214-7601-4F7F-9167-AFD7BBFFAAA5 Q37591327-4067F401-AED6-47DE-A570-416F410F0792 Q37621250-7EEB88A2-AEDF-4BE9-8DC2-BBEBF2472AD0 Q37684926-BFD99B19-1CC1-4DAB-83C4-862935772B99 Q37686246-D3A5FF34-A553-4465-A38F-98271426E6A7 Q37724200-C8CEEF05-4356-4396-BAB3-2B0B2FA169FA Q37753509-DC06740F-88B4-445F-B227-56243C4D96F9 Q37810697-69BF0370-9E2B-467D-B1EB-B5EB1B91011B Q37906364-8AC84C66-9908-400D-ADB3-3E72943E1C74 Q37947197-22EFB2D3-6719-476B-B6D7-1213B1CC513D Q37986036-F77DE7C8-EBF7-4105-B2AC-33068E18C6EF Q38135221-AD08AC61-6833-41ED-9D39-A9D7C9B04E7B Q38223118-C5D01FAF-6AF5-490B-B02E-2F1E6D16C67E Q38388068-AF016781-D6D2-4F5C-8B60-4461D4CDD95D Q38534263-F9E37BA4-C0CC-48BE-8B3F-A3CE0DED23AA Q38843694-0D071018-E650-4B08-BD61-6EA3920454AD Q38919786-FFE13021-6698-449F-BBEC-EDD62DC625DE Q39669156-85491699-145C-4D24-9407-D64FA2FBC810 Q43232740-F25DA6A3-725B-44C8-9329-E38B468FBB10 Q45870549-8C14697E-3F43-407A-A7D2-2D5B49E36370 Q46134947-33C4B281-4B8F-4640-AD14-ABE4445D50FB Q46142299-06F20783-5183-4C74-B2D0-4A882CFF4285

P2860

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial.

http://www.wikidata.org/entity/Q46606421

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Short-term effects of coenzyme ...... zed, placebo-controlled trial.

@en

Short-term effects of coenzyme ...... zed, placebo-controlled trial.

@nl

type

label

Short-term effects of coenzyme ...... zed, placebo-controlled trial.

@en

Short-term effects of coenzyme ...... zed, placebo-controlled trial.

@nl

prefLabel

Short-term effects of coenzyme ...... zed, placebo-controlled trial.

@en

Short-term effects of coenzyme ...... zed, placebo-controlled trial.

@nl

P1433

Q46606421-27E39A63-54B7-4FED-83D8-59FEADB90985

P1476

Q46606421-7C6B2F2F-D5E6-43D9-9D6D-76874088FC8B

P2093

Q46606421-2A07811B-6415-4001-A7BD-715D4106EB3E

Q46606421-30D8144E-EC51-41FB-85EA-FD30419D0D62

Q46606421-41CBF06B-CFC6-43E9-A282-1BA0FA1754AB

Q46606421-8BB69473-3438-4211-AA33-CED387691613

Q46606421-AFFA7AF1-C4CA-40D9-B947-3EE52AEA0F5F

Q46606421-C18B5886-C9E0-4EF9-87BF-FD7505090C37

Q46606421-C958C830-B3AB-4A7F-B18A-3F88A95E80EA

Q46606421-E85D2090-5C3E-4738-A76A-9AFBBDBF8E49

P2860

Q46606421-258BC7C7-B1E7-4DA9-9DAF-9ACDDF77344C

Q46606421-2875ED12-47C6-4753-A8AC-0135A5C4DE1D

Q46606421-2901CF72-48D0-4950-92C4-CF0087F99CC8

Q46606421-2AFBB09E-E529-46D5-815C-522B1FD4ED78

Q46606421-2E49DF53-F395-4E85-B05A-8C22A1657CDA

Q46606421-2E7DC862-5267-49C1-BF9C-D406AA2233B6

Q46606421-4F5140FF-72FE-4E27-8B9E-AA1D260C5E06

Q46606421-6AB74E1C-24B0-454E-BF6D-283EAEB29D26

Q46606421-76B4A09F-E399-4110-9D27-54032C4BF7E3

Q46606421-851160D7-3BCA-4591-8362-B76FF4B6BF06

P304

Q46606421-B206BF2C-F93F-4A2C-A3F0-FD8B521104DF

P31

Q46606421-713CBFFA-01F5-40DB-A3A4-26AE9BC4E1C9

P356

Q46606421-E4D5CA00-ED17-4BE6-84BE-F7103B1AFFA5

P407

Q46606421-F8FF068A-90A7-43CF-9A19-5C6A2EDB34F6

P433

Q46606421-3D68A664-9842-4EEC-8656-4AE03C26CD9B

P478

Q46606421-256E720A-558D-4594-AD57-129880DA757A

P50

Q46606421-4A308B8F-A219-49D5-A0AC-27BCBD706636

Q46606421-DCDA708E-0A21-4127-843F-5001E25E8F9B

Q46606421-F6E85EC6-2148-4437-A927-12D77E6C8F41

P577

Q46606421-46725EB7-73A2-4C4A-8DBC-052DF066149F

P698

Q46606421-24DD326C-6313-44E5-BDB2-55718D301A90

P921

Q46606421-20B68A81-7F8C-491C-8EE5-681449AE0A10

Q46606421-5F32B17C-9B0A-4536-B846-D312FD55B598

P356

P1433

Movement Disorders

P1476

Short-term effects of coenzyme ...... zed, placebo-controlled trial.

@en

P2093

Alexander Reuss

http://www.w3.org/2001/XMLSchema#string

Andrea Krisp

http://www.w3.org/2001/XMLSchema#string

Günter U Höglinger

http://www.w3.org/2001/XMLSchema#string

Jörg Magerkurth

http://www.w3.org/2001/XMLSchema#string

Karla M Eggert

http://www.w3.org/2001/XMLSchema#string

Petra Niklowitz

http://www.w3.org/2001/XMLSchema#string

Thomas Menke

http://www.w3.org/2001/XMLSchema#string

Ulrich Pilatus

http://www.w3.org/2001/XMLSchema#string

P2860

Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy.

Progressive supranuclear palsy: where are we now?

Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.

The FAB: a Frontal Assessment Battery at bedside.

Current and future treatments in progressive supranuclear palsy.

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

Mitochondrial dysfunction in progressive supranuclear palsy.

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Therapeutic role of coenzyme Q(10) in Parkinson's disease.

Phosphorylation status of liver by 31P-n.m.r. spectroscopy, and its implications for metabolic control. A comparison of 31P-n.m.r. spectroscopy (in vivo and in vitro) with chemical and enzymic determinations of ATP, ADP and Pi.

P304

942-949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.22023

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang H. Oertel

Carmen Schade-Brittinger

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18464278

http://www.w3.org/2001/XMLSchema#string

P921